Report Detail
Global and China Next Generation Cancer Diagnostic Devices Market Insights, Forecast to 2026
- RnM4189703 |
- 04 September, 2020 |
- Global |
- 141 Pages |
- QYResearch |
- Medical Devices & Consumables
Next Generation Cancer Diagnostic Devices market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Next Generation Cancer Diagnostic Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Next Generation Cancer Diagnostic Devices market is segmented into
Next Generation Sequencing
qPCR & Multiplexing
Lab-on- a- chip (LOAC)
Protein Microarrays
DNA Microarrays
Reverse Transcriptase-PCR (RT-PCR)
Segment by Application, the Next Generation Cancer Diagnostic Devices market is segmented into
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis
Regional and Country-level Analysis
The Next Generation Cancer Diagnostic Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Next Generation Cancer Diagnostic Devices market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Next Generation Cancer Diagnostic Devices Market Share Analysis
Next Generation Cancer Diagnostic Devices market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Next Generation Cancer Diagnostic Devices business, the date to enter into the Next Generation Cancer Diagnostic Devices market, Next Generation Cancer Diagnostic Devices product introduction, recent developments, etc.
The major vendors covered:
Roche Holding Ltd.（Switzerland)
Abbott Laboratories(US)
Siemens Healthcare(Germany)
Agilent Technologies Inc(Germany)
Illumina Inc.(US)
Becton Dickinson and Co.(US)
QIAGEN N.V.(Germany)
Affymetrix Inc.(US)
Johnson & Johnson(US)
Thermo Fisher Scientific Inc.(US)
GE Healthcare(England)
Life Technologies Corp.(US)
Luminex Corp.(US)
Cepheid Inc.(US)
Allegro Diagnostics Corp.(Brazil)
1 Study Coverage
- 1.1 Next Generation Cancer Diagnostic Devices Product Introduction
- 1.2 Market Segments
- 1.3 Key Next Generation Cancer Diagnostic Devices Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Type
- 1.4.2 Next Generation Sequencing
- 1.4.3 qPCR & Multiplexing
- 1.4.4 Lab-on- a- chip (LOAC)
- 1.4.5 Protein Microarrays
- 1.4.6 DNA Microarrays
- 1.4.7 Reverse Transcriptase-PCR (RT-PCR)
- 1.5 Market by Application
- 1.5.1 Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Application
- 1.5.2 Biomarker Development
- 1.5.3 CTC Analysis
- 1.5.4 Proteomic Analysis
- 1.5.5 Epigenetic Analysis
- 1.5.6 Genetic Analysis
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Next Generation Cancer Diagnostic Devices Market Size, Estimates and Forecasts
- 2.1.1 Global Next Generation Cancer Diagnostic Devices Revenue 2015-2026
- 2.1.2 Global Next Generation Cancer Diagnostic Devices Sales 2015-2026
- 2.2 Global Next Generation Cancer Diagnostic Devices, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Next Generation Cancer Diagnostic Devices Historical Market Size by Region (2015-2020)
- 2.3.1 Global Next Generation Cancer Diagnostic Devices Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Next Generation Cancer Diagnostic Devices Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Next Generation Cancer Diagnostic Devices Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Region (2021-2026)
- 2.4.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Region (2021-2026)
3 Global Next Generation Cancer Diagnostic Devices Competitor Landscape by Players
- 3.1 Global Top Next Generation Cancer Diagnostic Devices Sales by Manufacturers
- 3.1.1 Global Next Generation Cancer Diagnostic Devices Sales by Manufacturers (2015-2020)
- 3.1.2 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Next Generation Cancer Diagnostic Devices Manufacturers by Revenue
- 3.2.1 Global Next Generation Cancer Diagnostic Devices Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Next Generation Cancer Diagnostic Devices Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Next Generation Cancer Diagnostic Devices Revenue in 2019
- 3.2.5 Global Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Next Generation Cancer Diagnostic Devices Price by Manufacturers
- 3.4 Global Next Generation Cancer Diagnostic Devices Manufacturing Base Distribution, Product Types
- 3.4.1 Next Generation Cancer Diagnostic Devices Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Next Generation Cancer Diagnostic Devices Product Type
- 3.4.3 Date of International Manufacturers Enter into Next Generation Cancer Diagnostic Devices Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Next Generation Cancer Diagnostic Devices Market Size by Type (2015-2020)
- 4.1.1 Global Next Generation Cancer Diagnostic Devices Sales by Type (2015-2020)
- 4.1.2 Global Next Generation Cancer Diagnostic Devices Revenue by Type (2015-2020)
- 4.1.3 Next Generation Cancer Diagnostic Devices Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Next Generation Cancer Diagnostic Devices Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Type (2021-2026)
- 4.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Type (2021-2026)
- 4.2.3 Next Generation Cancer Diagnostic Devices Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Next Generation Cancer Diagnostic Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Next Generation Cancer Diagnostic Devices Market Size by Application (2015-2020)
- 5.1.1 Global Next Generation Cancer Diagnostic Devices Sales by Application (2015-2020)
- 5.1.2 Global Next Generation Cancer Diagnostic Devices Revenue by Application (2015-2020)
- 5.1.3 Next Generation Cancer Diagnostic Devices Price by Application (2015-2020)
- 5.2 Next Generation Cancer Diagnostic Devices Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Application (2021-2026)
- 5.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Next Generation Cancer Diagnostic Devices Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
- 6.1 China Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2015-2026
- 6.1.1 China Next Generation Cancer Diagnostic Devices Sales YoY Growth 2015-2026
- 6.1.2 China Next Generation Cancer Diagnostic Devices Revenue YoY Growth 2015-2026
- 6.1.3 China Next Generation Cancer Diagnostic Devices Market Share in Global Market 2015-2026
- 6.2 China Next Generation Cancer Diagnostic Devices Market Size by Players (International and Local Players)
- 6.2.1 China Top Next Generation Cancer Diagnostic Devices Players by Sales (2015-2020)
- 6.2.2 China Top Next Generation Cancer Diagnostic Devices Players by Revenue (2015-2020)
- 6.3 China Next Generation Cancer Diagnostic Devices Historic Market Review by Type (2015-2020)
- 6.3.1 China Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2015-2020)
- 6.3.2 China Next Generation Cancer Diagnostic Devices Revenue Market Share by Type (2015-2020)
- 6.3.3 China Next Generation Cancer Diagnostic Devices Price by Type (2015-2020)
- 6.4 China Next Generation Cancer Diagnostic Devices Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 China Next Generation Cancer Diagnostic Devices Sales Forecast by Type (2021-2026)
- 6.4.2 China Next Generation Cancer Diagnostic Devices Revenue Forecast by Type (2021-2026)
- 6.4.3 China Next Generation Cancer Diagnostic Devices Price Forecast by Type (2021-2026)
- 6.5 China Next Generation Cancer Diagnostic Devices Historic Market Review by Application (2015-2020)
- 6.5.1 China Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2015-2020)
- 6.5.2 China Next Generation Cancer Diagnostic Devices Revenue Market Share by Application (2015-2020)
- 6.5.3 China Next Generation Cancer Diagnostic Devices Price by Application (2015-2020)
- 6.6 China Next Generation Cancer Diagnostic Devices Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 China Next Generation Cancer Diagnostic Devices Sales Forecast by Application (2021-2026)
- 6.6.2 China Next Generation Cancer Diagnostic Devices Revenue Forecast by Application (2021-2026)
- 6.6.3 China Next Generation Cancer Diagnostic Devices Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2015-2026
- 7.2 North America Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country
- 7.2.1 North America Next Generation Cancer Diagnostic Devices Sales by Country (2015-2020)
- 7.2.2 North America Next Generation Cancer Diagnostic Devices Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2015-2026
- 8.2 Europe Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country
- 8.2.1 Europe Next Generation Cancer Diagnostic Devices Sales by Country
- 8.2.2 Europe Next Generation Cancer Diagnostic Devices Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country
- 9.2.1 Asia Pacific Next Generation Cancer Diagnostic Devices Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Next Generation Cancer Diagnostic Devices Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2015-2026
- 10.2 Latin America Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country
- 10.2.1 Latin America Next Generation Cancer Diagnostic Devices Sales by Country
- 10.2.2 Latin America Next Generation Cancer Diagnostic Devices Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Next Generation Cancer Diagnostic Devices Sales by Country
- 11.2.2 Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E
12 Company Profiles
- 12.1 Roche Holding Ltd.（Switzerland)
- 12.1.1 Roche Holding Ltd.（Switzerland) Corporation Information
- 12.1.2 Roche Holding Ltd.（Switzerland) Description and Business Overview
- 12.1.3 Roche Holding Ltd.（Switzerland) Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Products Offered
- 12.1.5 Roche Holding Ltd.（Switzerland) Recent Development
- 12.2 Abbott Laboratories(US)
- 12.2.1 Abbott Laboratories(US) Corporation Information
- 12.2.2 Abbott Laboratories(US) Description and Business Overview
- 12.2.3 Abbott Laboratories(US) Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Products Offered
- 12.2.5 Abbott Laboratories(US) Recent Development
- 12.3 Siemens Healthcare(Germany)
- 12.3.1 Siemens Healthcare(Germany) Corporation Information
- 12.3.2 Siemens Healthcare(Germany) Description and Business Overview
- 12.3.3 Siemens Healthcare(Germany) Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Products Offered
- 12.3.5 Siemens Healthcare(Germany) Recent Development
- 12.4 Agilent Technologies Inc(Germany)
- 12.4.1 Agilent Technologies Inc(Germany) Corporation Information
- 12.4.2 Agilent Technologies Inc(Germany) Description and Business Overview
- 12.4.3 Agilent Technologies Inc(Germany) Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Products Offered
- 12.4.5 Agilent Technologies Inc(Germany) Recent Development
- 12.5 Illumina Inc.(US)
- 12.5.1 Illumina Inc.(US) Corporation Information
- 12.5.2 Illumina Inc.(US) Description and Business Overview
- 12.5.3 Illumina Inc.(US) Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
- 12.5.5 Illumina Inc.(US) Recent Development
- 12.6 Becton Dickinson and Co.(US)
- 12.6.1 Becton Dickinson and Co.(US) Corporation Information
- 12.6.2 Becton Dickinson and Co.(US) Description and Business Overview
- 12.6.3 Becton Dickinson and Co.(US) Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Products Offered
- 12.6.5 Becton Dickinson and Co.(US) Recent Development
- 12.7 QIAGEN N.V.(Germany)
- 12.7.1 QIAGEN N.V.(Germany) Corporation Information
- 12.7.2 QIAGEN N.V.(Germany) Description and Business Overview
- 12.7.3 QIAGEN N.V.(Germany) Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Products Offered
- 12.7.5 QIAGEN N.V.(Germany) Recent Development
- 12.8 Affymetrix Inc.(US)
- 12.8.1 Affymetrix Inc.(US) Corporation Information
- 12.8.2 Affymetrix Inc.(US) Description and Business Overview
- 12.8.3 Affymetrix Inc.(US) Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
- 12.8.5 Affymetrix Inc.(US) Recent Development
- 12.9 Johnson & Johnson(US)
- 12.9.1 Johnson & Johnson(US) Corporation Information
- 12.9.2 Johnson & Johnson(US) Description and Business Overview
- 12.9.3 Johnson & Johnson(US) Sales, Revenue and Gross Margin (2015-2020)
- 12.9.4 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Products Offered
- 12.9.5 Johnson & Johnson(US) Recent Development
- 12.10 Thermo Fisher Scientific Inc.(US)
- 12.10.1 Thermo Fisher Scientific Inc.(US) Corporation Information
- 12.10.2 Thermo Fisher Scientific Inc.(US) Description and Business Overview
- 12.10.3 Thermo Fisher Scientific Inc.(US) Sales, Revenue and Gross Margin (2015-2020)
- 12.10.4 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
- 12.10.5 Thermo Fisher Scientific Inc.(US) Recent Development
- 12.11 Roche Holding Ltd.（Switzerland)
- 12.11.1 Roche Holding Ltd.（Switzerland) Corporation Information
- 12.11.2 Roche Holding Ltd.（Switzerland) Description and Business Overview
- 12.11.3 Roche Holding Ltd.（Switzerland) Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Products Offered
- 12.11.5 Roche Holding Ltd.（Switzerland) Recent Development
- 12.12 Life Technologies Corp.(US)
- 12.12.1 Life Technologies Corp.(US) Corporation Information
- 12.12.2 Life Technologies Corp.(US) Description and Business Overview
- 12.12.3 Life Technologies Corp.(US) Sales, Revenue and Gross Margin (2015-2020)
- 12.12.4 Life Technologies Corp.(US) Products Offered
- 12.12.5 Life Technologies Corp.(US) Recent Development
- 12.13 Luminex Corp.(US)
- 12.13.1 Luminex Corp.(US) Corporation Information
- 12.13.2 Luminex Corp.(US) Description and Business Overview
- 12.13.3 Luminex Corp.(US) Sales, Revenue and Gross Margin (2015-2020)
- 12.13.4 Luminex Corp.(US) Products Offered
- 12.13.5 Luminex Corp.(US) Recent Development
- 12.14 Cepheid Inc.(US)
- 12.14.1 Cepheid Inc.(US) Corporation Information
- 12.14.2 Cepheid Inc.(US) Description and Business Overview
- 12.14.3 Cepheid Inc.(US) Sales, Revenue and Gross Margin (2015-2020)
- 12.14.4 Cepheid Inc.(US) Products Offered
- 12.14.5 Cepheid Inc.(US) Recent Development
- 12.15 Allegro Diagnostics Corp.(Brazil)
- 12.15.1 Allegro Diagnostics Corp.(Brazil) Corporation Information
- 12.15.2 Allegro Diagnostics Corp.(Brazil) Description and Business Overview
- 12.15.3 Allegro Diagnostics Corp.(Brazil) Sales, Revenue and Gross Margin (2015-2020)
- 12.15.4 Allegro Diagnostics Corp.(Brazil) Products Offered
- 12.15.5 Allegro Diagnostics Corp.(Brazil) Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Next Generation Cancer Diagnostic Devices Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Next Generation Cancer Diagnostic Devices Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Next Generation Cancer Diagnostic Devices. Industry analysis & Market Report on Next Generation Cancer Diagnostic Devices is a syndicated market report, published as Global and China Next Generation Cancer Diagnostic Devices Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Next Generation Cancer Diagnostic Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
